Tamsulosin Hydrochloride
- Product NDC
- 50268-740
- Requested package NDC
- 50268-740-15
- 11-digit product format
- 502680740
- Labeler code
- 50268
- Product ID
- 50268-740_41c4deb3-2dcf-b17a-e063-6294a90ad2be
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tamsulosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA207405
- Marketing category
- ANDA
- Marketing start
- 2018-01-17
- Substance
- TAMSULOSIN HYDROCHLORIDE
- Active strength
- .4 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207405-001 | TAMSULOSIN HYDROCHLORIDE | TAMSULOSIN HYDROCHLORIDE | 0.4MG | CAPSULE / ORAL | AB | 2017-08-11 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207405-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A207405-001 | TAMSULOSIN HYDROCHLORIDE | 0.4MG | CAPSULE / ORAL | AB | 2017-08-11 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A207405-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tamsulosin Hydrochloride | TAMSULOSIN HYDROCHLORIDE | Chartwell RX, LLC | 14db58df-7584-410b-8cf4-4b928dada859 | 2025-12-11 | Warnings, Adverse reactions | 207405 ANDA207405 |
| Tamsulosin Hydrochloride | TAMSULOSIN HYDROCHLORIDE | AvPAK | 62fa7fdf-c588-6f79-e053-2a91aa0a4c19 | 2025-10-22 | Warnings, Adverse reactions | 207405 ANDA207405 50268-740-15 50268-740 50268074015 |
| Tamsulosin Hydrochloride | TAMSULOSIN HYDROCHLORIDE | Golden State Medical Supply, Inc. | 18e9741b-969a-5a87-e063-6294a90a8851 | 2025-10-13 | Warnings, Adverse reactions | 207405 ANDA207405 |
| Tamsulosin Hydrochloride | TAMSULOSIN HYDROCHLORIDE | Bryant Ranch Prepack | f185abfc-367d-45da-87c4-86d9f70bcd5d | 2025-09-29 | Warnings, Adverse reactions | 207405 ANDA207405 |
| Tamsulosin Hydrochloride | TAMSULOSIN HYDROCHLORIDE | Ascend Laboratories, LLC | ed9988bc-0759-4c36-bee1-11b68dc1c84c | 2025-08-04 | Warnings, Adverse reactions | 207405 ANDA207405 |
| Tamsulosin Hydrochloride | TAMSULOSIN HYDROCHLORIDE | A-S Medication Solutions | 3a05970e-6c34-4dff-9fd7-dde8ce60f280 | 2023-10-03 | Warnings, Adverse reactions | 207405 ANDA207405 |
| Tamsulosin Hydrochloride | TAMSULOSIN HYDROCHLORIDE | A-S Medication Solutions | 74a8ef78-908f-4671-91a3-ec3a044aabf2 | 2023-09-21 | Warnings, Adverse reactions | 207405 ANDA207405 |
| Tamsulosin Hydrochloride | TAMSULOSIN HYDROCHLORIDE | Proficient Rx LP | 06b44e53-c6e7-4e12-a8fd-572d092cfa70 | 2020-02-01 | Warnings, Adverse reactions | 207405 ANDA207405 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tamsulosin Hydrochloride
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| TAMSULOSIN HYDROCHLORIDE | .4 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 11SV1951MR | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 863669 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 62fa7fdf-c588-6f79-e053-2a91aa0a4c19 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| ee39297f-c54b-4394-13fa-e0de7b5b9070 | Product name | 4 | 20250305 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
| ae349df8-97ce-a639-ed32-50a4cb01b1bd | Product name | 4 | 20200313 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50268-740-01 | Tamsulosin Hydrochloride | 100 in 1 BOX | CAPSULE | 100 | 11 | |
| 50268-740-11 | Tamsulosin Hydrochloride | 1 in 1 BLISTER PACK | CAPSULE | 1 | 11 | |
| 50268-740-15 | Tamsulosin Hydrochloride | 50 in 1 BOX, UNIT-DOSE | CAPSULE | 50 | 11 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50268-740-01 | EA - Each | 50268-740 | d2dc1b0d-b70e-4428-9a17-07a2740186d7 | 1 | 2025-12-16 |
| 50268-740-11 | EA - Each | 50268-740 | b6c8c492-bbd4-4677-80fb-c2a061bdfda1 | 1 | 2018-03-08 |
| 50268-740-15 | EA - Each | 50268-740 | 354ae719-106e-422f-afe3-78645693680b | 1 | 2018-03-08 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 863669 | tamsulosin HCl 0.4 MG Oral Capsule | PSN | 62fa7fdf-c588-6f79-e053-2a91aa0a4c19 | 11 |
| 863669 | tamsulosin hydrochloride 0.4 MG Oral Capsule | SCD | 62fa7fdf-c588-6f79-e053-2a91aa0a4c19 | 11 |
| 863669 | tamsulosin HCl 0.4 MG Modified Release Oral Capsule | SY | 62fa7fdf-c588-6f79-e053-2a91aa0a4c19 | 11 |
| 863669 | tamsulosin HCl 0.4 MG Oral Capsule | PSN | 1e044a8a-c3ee-defc-e063-6394a90a6061 | 1 |
| 863669 | tamsulosin hydrochloride 0.4 MG Oral Capsule | SCD | 1e044a8a-c3ee-defc-e063-6394a90a6061 | 1 |
| 863669 | tamsulosin HCl 0.4 MG Modified Release Oral Capsule | SY | 1e044a8a-c3ee-defc-e063-6394a90a6061 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 50268-740-15 | 50268074015 | 50 BLISTER PACK in 1 BOX, UNIT-DOSE (50268-740-15) / 1 CAPSULE in 1 BLISTER PACK (50268-740-11) | 50 blister pack | 2018-01-17 | 0000-00-00 | No | No | Current |